Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries

Respiratory syncytial virus (RSV) infection occurs commonly in infants aged ≤2 years, and severe infection results in hospitalization with accompanying morbidity and mortality. Palivizumab has been available for prophylaxis for the past 15 years. Prospective data on patients who received palivizumab...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Paes, Bosco, Mitchell, Ian, Li, Abby, Harimoto, Tetsuhiro, Lanctôt, Krista L.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3703731/
https://ncbi.nlm.nih.gov/pubmed/23861694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/917068
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares